(Q39652034)

13 September 2017

1 reference

title

Antipyrine as a model drug to study hepatic drug-metabolizing capacity (English)

1 reference

13 September 2017

Poulsen HE

1

1 reference

13 September 2017

Loft S

series ordinal

2

1 reference

13 September 2017

publication date

1 June 1988

1 reference

13 September 2017

published in

Journal of Hepatology

1 reference

13 September 2017

volume

6

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

374-382

1 reference

Two compartment analysis of plasma elimination of phenazone in normals and in patients with cirrhosis of the liver

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Differential effects of enzyme induction on antipyrine metabolite formation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

The absence of significant biliary excretion of antipyrine or its metabolites in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine metabolite formation and excretion in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Differential induction of antipyrine metabolism by rifampicin.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine metabolism during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Influence of cimetidine on steady state concentration and metabolite formation from antipyrine infused with a rectal osmotic mini pump

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

A simple method for determination of antipyrine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Optimal sampling times for minimum variance of clearance determination.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

A one-sample method for antipyrine clearance determination in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Clearance of antipyrine-dependence of quantitative liver function

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Cholic acid conjugation test and quantitative liver function in acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine kinetics in liver disease and liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine elimination in patients with obstructive jaundice: a predictor of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine clearance in patients with Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effect of surgery on liver function in patients with liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Influence of sex and oral contraceptive steroids on antipyrine metabolite formation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effects of parenteral nutritional regimens on oxidative drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effect of charcoal-broiled beef on antipyrine and theophylline metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Stimulatory effect of brussels sprouts and cabbage on human drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Ethanol and antipyrine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Genetic and environmental factors affecting ethanol metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Hepatic drug metabolism and physical fitness.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Influence of bed rest on the pharmacokinetics of phenazone

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effects of growth hormone on antipyrine kinetics in children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine clearance in pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

The effect of fever on antipyrine metabolism in children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Hepatic antipyrine metabolism in malnourished patients: influence of the type of malnutrition and course after nutritional rehabilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Unaltered metabolism of antipyrine and tolbutamide in fasting man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effect of surgery under general anaesthesia on antipyrine clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine metabolism in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Variation of microsomal mixed function oxidase(s) and human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Elimination of antipyrine and benzo[a]pyrene metabolism in cultured human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Influence of alaproclate on antipyrine metabolite formation in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effect of chloroquine and primaquine on antipyrine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

The Effect of Spironolactone on Antipyrine Metabolism in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2888%2980057-6

7 January 2021

10.1016/S0168-8278(88)80057-6

Identifiers

DOI

1 reference

13 September 2017

1 reference